Endothelin receptor type B
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 2 PDB declaration: dimeric(2) Consistent with protein copy count | Chain R; UniProt 66–407 | Not recorded | Endothelin-1 × 1 (P05305) | ELECTRON MICROSCOPY cryo-EM buffer:pH 7.5 cryo-EM vitrification conditions:Cryogen ETHANE | Resolution 3.62 Å |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 8ZRT | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 5X93 Human endothelin receptor type-B in complex with antagonist K-8794 Deposited 2017-03-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
66–303(238 aa)
Chain A
311–407(97 aa)
|
Mutation:R124Y,D154A,K270A,C1054A,I1094R,S342A,I381A,C396A,C400A,C405A Mutation:R124Y,D154A,K270A,C1054A,I1094R,S342A,I381A,C396A,C400A,C405A | K87 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]oxy-N-(2,6-dimethylphenyl)propanamide × 1 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 11 CLR CHOLESTEROL × 1 SO4 SULFATE ION × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293 K;PEG 500 DME, (NH4)2SO4, MOPS
|
Resolution 2.20 Å R-free 0.239 |
| 5XPR Human endothelin receptor type-B in complex with antagonist bosentan Deposited 2017-06-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
66–303(238 aa)
Chain A
311–407(97 aa)
|
Mutation:R124Y,K270A,C1054A,I1094R,S342A,I381A,C396A,C400A,C405A Mutation:R124Y,K270A,C1054A,I1094R,S342A,I381A,C396A,C400A,C405A | K86 4-tert-butyl-N-[6-(2-hydroxyethyloxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide × 1 SO4 SULFATE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293 K;PEG 500 DME, Na2SO4, MOPS
|
Resolution 3.60 Å R-free 0.297 |
| 6IGK Crystal Structure of human ETB receptor in complex with Endothelin-3 Deposited 2018-09-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
66–303(238 aa)
Chain A
311–407(97 aa)
|
Mutation:R124Y,D154A,K270A,C1052T,C1095A,S342A,I381A,C396A,C400A,C405A Mutation:R124Y,D154A,K270A,C1052T,C1095A,S342A,I381A,C396A,C400A,C405A | OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 12 CIT CITRIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293 K;PEG 500DME, Ammonium citrate tribasic
|
Resolution 2.00 Å R-free 0.227 |
| 6IGL Crystal Structure of human ETB receptor in complex with IRL1620 Deposited 2018-09-25 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
66–303(238 aa)
Chain A
311–407(97 aa)
|
Mutation:R124Y,D154A,K270A,C1052T,C1095A,S342A,I381A,C396A,C400A,C405A Mutation:R124Y,D154A,K270A,C1052T,C1095A,S342A,I381A,C396A,C400A,C405A | CIT CITRIC ACID × 1 SO4 SULFATE ION × 4 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5;293 K;PEG 500DME, (NH4)2SO4 or NH4Cl
|
Resolution 2.70 Å R-free 0.241 |
| 6K1Q Human endothelin receptor type-B in complex with inverse agonist IRL2500 Deposited 2019-05-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
66–303(238 aa)
Chain A
311–407(97 aa)
|
Mutation:;R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A,R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A,R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A ; Mutation:;R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A,R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A,R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A ; | D2U (2~{S})-2-[[(2~{R})-2-[(3,5-dimethylphenyl)carbonyl-methyl-amino]-3-(4-phenylphenyl)propanoyl]amino]-3-(1~{H}-indol-3-yl)propanoic acid × 1 PO4 PHOSPHATE ION × 4 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 8 |
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7.5;293 K;30% PEG300, 150 mM NaH2PO4,10 mM TCEP, 100 mM Bis-tris
|
Resolution 2.70 Å R-free 0.265 |
| 6LRY Crystal structure of human endothelin ETB receptor in complex with sarafotoxin S6b Deposited 2020-01-16 | Different construct Different mutation/modification Different oligomeric state Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
66–303(238 aa)
Chain A
311–407(97 aa)
|
Mutation:R124Y,D154A,K270A,C1052T,C1095A,S342A,I381A,C396A,C400A,C405A Mutation:R124Y,D154A,K270A,C1052T,C1095A,S342A,I381A,C396A,C400A,C405A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 5;293 K;PEG 600, Ammonium sulfate
|
Resolution 3.00 Å R-free 0.304 |
| 8HBD Cryo-EM structure of IRL1620-bound ETBR-Gi complex Deposited 2022-10-28 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain R
27–424(398 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.04
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.99 Å |
| 8HCX Cryo-EM structure of Endothelin1-bound ETBR-Gq complex Deposited 2022-11-03 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 6 PDB declaration: hexameric |
Chain C
27–424(398 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å |
| 8XVE Cryo-EM structure of ETBR bound with BQ3020 Deposited 2024-01-15 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 6 PDB declaration: hexameric |
Chain R
67–406(340 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å |
| 8XVH Cryo-EM structure of ETBR bound with Endothelin1 Deposited 2024-01-15 | Different construct Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 6 PDB declaration: hexameric |
Chain R
67–406(340 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.26 Å |
| 8XWP Cryo-EM structure of ET-1 bound ETBR-DNGI complex Deposited 2024-01-16 | Different oligomeric state Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain R
66–407(342 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.21 Å |
| 8XWQ Cryo-EM structure of ET-1 bound ETBR-DNGI complex Deposited 2024-01-16 | Different oligomeric state Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric |
Chain R
66–407(342 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.60 Å |
12 other PDB entries and 12 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | EDNRB_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain R; PDBConstruct 5–346; UniProt 66–407 |